165 related articles for article (PubMed ID: 38791495)
1. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.
Donate-Correa J; Martín-Núñez E; Hernández-Carballo C; González-Luis A; Mora-Fernández C; Martín-Olivera A; Rodríguez-Ramos S; Cerro-López P; López-Castillo Á; Delgado-Molinos A; López-Tarruella VC; Navarro-González JF
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791495
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.
Egli-Spichtig D; Imenez Silva PH; Glaudemans B; Gehring N; Bettoni C; Zhang MYH; Pastor-Arroyo EM; Schönenberger D; Rajski M; Hoogewijs D; Knauf F; Misselwitz B; Frey-Wagner I; Rogler G; Ackermann D; Ponte B; Pruijm M; Leichtle A; Fiedler GM; Bochud M; Ballotta V; Hofmann S; Perwad F; Föller M; Lang F; Wenger RH; Frew I; Wagner CA
Kidney Int; 2019 Oct; 96(4):890-905. PubMed ID: 31301888
[TBL] [Abstract][Full Text] [Related]
4. Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.
Wallquist C; Mansouri L; Norrbäck M; Hylander B; Jacobson SH; Larsson TE; Lundahl J
Nephron; 2018; 138(4):287-295. PubMed ID: 29301137
[TBL] [Abstract][Full Text] [Related]
5. Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.
Bansal S; Friedrichs WE; Velagapudi C; Feliers D; Khazim K; Horn D; Cornell JE; Werner SL; Fanti P
Nephrol Dial Transplant; 2017 Jun; 32(6):960-968. PubMed ID: 27836924
[TBL] [Abstract][Full Text] [Related]
6. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
[TBL] [Abstract][Full Text] [Related]
8. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults.
Hanks LJ; Casazza K; Judd SE; Jenny NS; Gutiérrez OM
PLoS One; 2015; 10(3):e0122885. PubMed ID: 25811862
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease.
Yamamura-Miyazaki N; Michigami T; Ozono K; Yamamoto K; Hasuike Y
Clin Exp Nephrol; 2022 Oct; 26(10):1014-1021. PubMed ID: 35612637
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23 and Inflammation in CKD.
Munoz Mendoza J; Isakova T; Ricardo AC; Xie H; Navaneethan SD; Anderson AH; Bazzano LA; Xie D; Kretzler M; Nessel L; Hamm LL; Negrea L; Leonard MB; Raj D; Wolf M;
Clin J Am Soc Nephrol; 2012 Jul; 7(7):1155-62. PubMed ID: 22554719
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T
Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
[TBL] [Abstract][Full Text] [Related]
12. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
13. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
[TBL] [Abstract][Full Text] [Related]
15. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
Kanda E; Yoshida M; Sasaki S
BMC Nephrol; 2012 Sep; 13():122. PubMed ID: 23013306
[TBL] [Abstract][Full Text] [Related]
16. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
Czaya B; Faul C
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461904
[TBL] [Abstract][Full Text] [Related]
17. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
David V; Martin A; Isakova T; Spaulding C; Qi L; Ramirez V; Zumbrennen-Bullough KB; Sun CC; Lin HY; Babitt JL; Wolf M
Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
[TBL] [Abstract][Full Text] [Related]
20. Update on fibroblast growth factor 23 in chronic kidney disease.
Wolf M
Kidney Int; 2012 Oct; 82(7):737-47. PubMed ID: 22622492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
